Clinical Trials

Imagine a world where those living with Type 1 Diabetes, a chronic illness affecting more than 60 million adults globally, no longer had to deal with regular blood glucose monitoring, daily insulin injections or life-threatening nighttime hypoglycemic events, but...

SAGA Diagnostics AB, a cancer liquid biopsy and genomic testing company focused on precision oncology and non-invasive ultrasensitive monitoring of cancer patients, announces it has entered service agreements with the international pharmaceutical company Servier, based in Paris, France. “These deals...

PHARMASEAL, a new provider of clinical trial management (CTMS) and governance solutions to enter the market, is celebrating a year of significant success, with 2019 marking several important milestones for the company. This includes winning Start-Up of the Year...

Bionetix, a biotech company developing novel oncology drugs; ProQinase, an oncology-focused contract research organization (CRO) recently acquired by Reaction Biology Corporation (Malvern/PA, USA); and MercachemSyncom, a chemistry CRO specializing in medicinal chemistry and comprehensive medicinal chemistry (CMC), announced they...

Scientists working across drug metabolism and pharmacokinetics, bioanalytical, pre-clinical and clinical trial applications can now access a range of digital reagent dispensers designed to enable assay miniaturization, boost productivity and improve accuracy of results. Offering enhanced dispensing precision, the...

Epizyme, Inc., a biopharmaceutical company developing novel epigenetic therapies, announced that the U.S. FDA has granted accelerated approval of TAZVERIK for the treatment of adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid...

Greenphire, the global leader in financial software for clinical trials, announced that it has expanded its ConneX global travel solution to include additional in-market support and visa fulfillment services. Used by more than 40 pharmaceutical companies (7 of the top...